Leukemia vaccine trial shows 41% lower risk of death
FNC · Aired · 4m 44s
Already a subscriber?
Sellas Life Sciences CEO and founder Angelos Stergiou joins 'Fox & Friends' to discuss trial results for a new acute myeloid leukemia vaccine.
FNC · Aired · 4m 44s
Sellas Life Sciences CEO and founder Angelos Stergiou joins 'Fox & Friends' to discuss trial results for a new acute myeloid leukemia vaccine.